Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Navigation/Suche

• Forscher*innen.
• Institutionen.
• Projekte.
• Publikationen.
• Partner.
• Geldgeber.
• Ausstattung.
• Knowhow.
• Forschungsfelder.

Publikationen

Suchbegriffe: CHEMOTHERAPY, ADJUVANT - , . Treffer: 102

2020

Dubsky, PC; Singer, CF; Egle, D; Wette, V; Petru, E; Balic, M; Pichler, A; Greil, R; Petzer, AL; Bago-Horvath, Z; Fesl, C; Meek, SM; Kronenwett, R; Rudas, M; Gnant, M; Filipits, M; Austrian Breast and Colorectal Cancer Study Group The EndoPredict score predicts response to neoadjuvant chemotherapy and neoendocrine therapy in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer patients from the ABCSG-34 trial.
Eur J Cancer. 2020; 134:99-106 Doi: 10.1016/j.ejca.2020.04.020 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Eggermont, AMM; Rutkowski, P; Dutriaux, C; Hofman-Wellenhof, R; Dziewulski, P; Marples, M; Grange, F; Lok, C; Pennachioli, E; Robert, C; van Akkooi, ACJ; Bastholt, L; Minisini, A; Marshall, E; Salès, F; Grob, JJ; Bechter, O; Schadendorf, D; Marreaud, S; Kicinski, M; Suciu, S; Testori, AAE Adjuvant therapy with pegylated interferon-alfa2b vs observation in stage II B/C patients with ulcerated primary: Results of the European Organisation for Research and Treatment of Cancer 18081 randomised trial.
Eur J Cancer. 2020; 133(8):94-103 Doi: 10.1016/j.ejca.2020.04.015
Web of Science PubMed FullText FullText_MUG

 

2017

Riedl, JM; Posch, F; Bezan, A; Szkandera, J; Smolle, MA; Winder, T; Rossmann, CH; Schaberl-Moser, R; Pichler, M; Stotz, M; Stöger, H; Gerger, A Patterns of venous thromboembolism risk in patients with localized colorectal cancer undergoing adjuvant chemotherapy or active surveillance: an observational cohort study.
BMC Cancer. 2017; 17(1):415-415 Doi: 10.1186/s12885-017-3392-4 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Schramm, A; Schochter, F; Friedl, TWP; de Gregorio, N; Andergassen, U; Alunni-Fabbroni, M; Trapp, E; Jaeger, B; Heinrich, G; Camara, O; Decker, T; Ober, A; Mahner, S; Fehm, TN; Pantel, K; Fasching, PA; Schneeweiss, A; Janni, W; Rack, BK; SUCCESS Study Group Prevalence of Circulating Tumor Cells After Adjuvant Chemotherapy With or Without Anthracyclines in Patients With HER2-negative, Hormone Receptor-positive Early Breast Cancer.
Clin Breast Cancer. 2017; 17(4):279-285 Doi: 10.1016/j.clbc.2016.11.008
Web of Science PubMed FullText FullText_MUG

 

Terbuch, A; Posch, F; Annerer, LM; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Partl, R; Kapp, KS; Stöger, H; Gerger, A; Stotz, M Long-term cardiovascular complications in stage I seminoma patients.
Clin Transl Oncol. 2017; 19(11):1400-1408 Doi: 10.1007/s12094-017-1742-y [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2016

Hepp, P; Andergassen, U; Jäger, B; Trapp, E; Alunni-Fabbroni, M; Friedl, TW; Hecker, N; Lorenz, R; Fasching, P; Schneeweiss, A; Fehm, T; Janni, W; Rack, B Association of CA27.29 and Circulating Tumor Cells Before and at Different Times After Adjuvant Chemotherapy in Patients with Early-stage Breast Cancer - The SUCCESS Trial.
Anticancer Res. 2016; 36(9):4771-4776 Doi: 10.21873/anticanres.11034 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Kainhofer, V; Smolle, MA; Szkandera, J; Liegl-Atzwanger, B; Maurer-Ertl, W; Gerger, A; Riedl, J; Leithner, A The width of resection margins influences local recurrence in soft tissue sarcoma patients.
Eur J Surg Oncol. 2016; 42(6):899-906 Doi: 10.1016/j.ejso.2016.03.026
Web of Science PubMed FullText FullText_MUG

 

Rack, B; Jückstock, J; Trapp, E; Weissenbacher, T; Alunni-Fabbroni, M; Schramm, A; Widschwendter, P; Lato, K; Zwingers, T; Lorenz, R; Tesch, H; Schneeweiss, A; Fasching, P; Mahner, S; Beckmann, MW; Lichtenegger, W; Janni, W; SUCCESS Study Group CA27.29 as a tumour marker for risk evaluation and therapy monitoring in primary breast cancer patients.
Tumour Biol. 2016; 37(10):13769-13775 Doi: 10.1007/s13277-016-5171-2
Web of Science PubMed FullText FullText_MUG

 

2015

Bossuyt, V; Provenzano, E; Symmans, WF; Boughey, JC; Coles, C; Curigliano, G; Dixon, JM; Esserman, LJ; Fastner, G; Kuehn, T; Peintinger, F; von Minckwitz, G; White, J; Yang, W; Badve, S; Denkert, C; MacGrogan, G; Penault-Llorca, F; Viale, G; Cameron, D; Breast International Group-North American Breast Cancer Group (BIG-NABCG) collaboration Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration.
ANN ONCOL. 2015; 26(7): 1280-1291. Doi: 10.1093/annonc/mdv161 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Peintinger, F; Sinn, B; Hatzis, C; Albarracin, C; Downs-Kelly, E; Morkowski, J; Gould, R; Symmans, WF Reproducibility of residual cancer burden for prognostic assessment of breast cancer after neoadjuvant chemotherapy.
MODERN PATHOL. 2015; 28(7): 913-920. Doi: 10.1038/modpathol.2015.53 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Rouprêt, M; Babjuk, M; Compérat, E; Zigeuner, R; Sylvester, RJ; Burger, M; Cowan, NC; Böhle, A; Van Rhijn, BW; Kaasinen, E; Palou, J; Shariat, SF European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update.
Eur Urol. 2015; 68(5):868-879 Doi: 10.1016/j.eururo.2015.06.044
Web of Science PubMed FullText FullText_MUG

 

Suppan, C; Bjelic-Radisic, V; La Garde, M; Groselj-Strele, A; Eberhard, K; Samonigg, H; Loibner, H; Dandachi, N; Balic, M Neutrophil/Lymphocyte ratio has no predictive or prognostic value in breast cancer patients undergoing preoperative systemic therapy.
BMC Cancer. 2015; 15:1027-1027 Doi: 10.1186/s12885-015-2005-3 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Szkandera, J; Herzog, S; Pichler, M; Stiegelbauer, V; Stotz, M; Schaberl-Moser, R; Samonigg, H; Asslaber, M; Lax, S; Leitner, G; Renner, W; Lenz, HJ; Berghold, A; Gerger, A LGR5 rs17109924 is a predictive genetic biomarker for time to recurrence in patients with colon cancer treated with 5-fluorouracil-based adjuvant chemotherapy.
Pharmacogenomics J. 2015; 15(5):391-396 Doi: 10.1038/tpj.2015.2 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Tsao, MS; Marguet, S; Le Teuff, G; Lantuejoul, S; Shepherd, FA; Seymour, L; Kratzke, R; Graziano, SL; Popper, HH; Rosell, R; Douillard, JY; Le-Chevalier, T; Pignon, JP; Soria, JC; Brambilla, EM Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection.
J Clin Oncol. 2015; 33(30):3439-3446 Doi: 10.1200/JCO.2014.58.8335 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2014

Gnant, M; Filipits, M; Greil, R; Stoeger, H; Rudas, M; Bago-Horvath, Z; Mlineritsch, B; Kwasny, W; Knauer, M; Singer, C; Jakesz, R; Dubsky, P; Fitzal, F; Bartsch, R; Steger, G; Balic, M; Ressler, S; Cowens, JW; Storhoff, J; Ferree, S; Schaper, C; Liu, S; Fesl, C; Nielsen, TO; Austrian Breast and Colorectal Cancer Study Group Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone.
Ann Oncol. 2014; 25(2):339-345 Doi: 10.1093/annonc/mdt494 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Ma, X; Rousseau, V; Sun, H; Lantuejoul, S; Filipits, M; Pirker, R; Popper, H; Mendiboure, J; Vataire, AL; Le Chevalier, T; Soria, JC; Brambilla, E; Dunant, A; Hainaut, P; IALT-Bio working group Significance of TP53 mutations as predictive markers of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer.
Mol Oncol. 2014; 8(3):555-564 Doi: 10.1016/j.molonc.2013.12.015 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Ning, Y; Gerger, A; Zhang, W; Hanna, DL; Yang, D; Winder, T; Wakatsuki, T; Labonte, MJ; Stintzing, S; Volz, N; Sunakawa, Y; Stremitzer, S; El-Khoueiry, R; Lenz, HJ Plastin polymorphisms predict gender- and stage-specific colon cancer recurrence after adjuvant chemotherapy.
Mol Cancer Ther. 2014; 13(2):528-539 Doi: 10.1158/1535-7163.MCT-13-0646 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Pircher, A; Gamerith, G; Amann, A; Reinold, S; Popper, H; Gächter, A; Pall, G; Wöll, E; Jamnig, H; Gastl, G; Wolf, AM; Hilbe, W; Wolf, D Neoadjuvant chemo-immunotherapy modifies CD4(+)CD25(+) regulatory T cells (Treg) in non-small cell lung cancer (NSCLC) patients.
Lung Cancer. 2014; 85(1): 81-87. Doi: 10.1016/j.lungcan.2014.04.001
Web of Science PubMed FullText FullText_MUG

 

Steger, GG; Greil, R; Lang, A; Rudas, M; Fitzal, F; Mlineritsch, B; Hartmann, BL; Bartsch, R; Melbinger, E; Hubalek, M; Stoeger, H; Dubsky, P; Ressler, S; Petzer, AL; Singer, CF; Muss, C; Jakesz, R; Gampenrieder, SP; Zielinski, CC; Fesl, C; Gnant, M Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24)
ANN ONCOL. 2014; 25(2): 366-371. Doi: 10.1093/annonc/mdt508 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Winder, T; Giamas, G; Wilson, PM; Zhang, W; Yang, D; Bohanes, P; Ning, Y; Gerger, A; Stebbing, J; Lenz, HJ Insulin-like growth factor receptor polymorphism defines clinical outcome in estrogen receptor-positive breast cancer patients treated with tamoxifen.
Pharmacogenomics J. 2014; 14(1):28-34 Doi: 10.1038/tpj.2013.8
Web of Science PubMed FullText FullText_MUG

 

2013

Babjuk, M; Burger, M; Zigeuner, R; Shariat, SF; van Rhijn, BW; Compérat, E; Sylvester, RJ; Kaasinen, E; Böhle, A; Palou Redorta, J; Rouprêt, M; European Association of Urology EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013.
Eur Urol. 2013; 64(4):639-653 Doi: 10.1016/j.eururo.2013.06.003
Web of Science PubMed FullText FullText_MUG

 

Basharkhah, A; Pansy, J; Urban, C; Höllwarth, ME Outcomes after interdisciplinary management of 7 patients with Askin tumor.
Pediatr Surg Int. 2013; 29(5):431-436 Doi: 10.1007/s00383-013-3272-1
Web of Science PubMed FullText FullText_MUG

 

Dubsky, P; Filipits, M; Jakesz, R; Rudas, M; Singer, CF; Greil, R; Dietze, O; Luisser, I; Klug, E; Sedivy, R; Bachner, M; Mayr, D; Schmidt, M; Gehrmann, MC; Petry, C; Weber, KE; Kronenwett, R; Brase, JC; Gnant, M; Austrian Breast and Colorectal Cancer Study Group (ABCSG). EndoPredict improves the prognostic classification derived from common clinical guidelines in ER-positive, HER2-negative early breast cancer.
Ann Oncol. 2013; 24(3):640-647 Doi: 10.1093/annonc/mds334 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Fajkovic, H; Cha, EK; Jeldres, C; Robinson, BD; Rink, M; Xylinas, E; Chromecki, TF; Breinl, E; Svatek, RS; Donner, G; Tagawa, ST; Tilki, D; Bastian, PJ; Karakiewicz, PI; Volkmer, BG; Novara, G; Joual, A; Faison, T; Sonpavde, G; Daneshmand, S; Lotan, Y; Scherr, DS; Shariat, SF Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis.
Eur Urol. 2013; 64(5):837-845 Doi: 10.1016/j.eururo.2012.07.026
Web of Science PubMed FullText FullText_MUG

 

Gnant, M; Pfeiler, G; Stöger, H; Mlineritsch, B; Fitzal, F; Balic, M; Kwasny, W; Seifert, M; Stierer, M; Dubsky, P; Greil, R; Steger, G; Samonigg, H; Fesl, C; Jakesz, R The predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the randomised ABCSG-6a trial.
Br J Cancer. 2013; 109(3):589-596 Doi: 10.1038/bjc.2013.367 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Graziano, SL; Lacas, B; Vollmer, R; Kratzke, R; Popper, H; Filipits, M; Seymour, L; Shepherd, FA; Rosell, R; Veillard, AS; Taron, M; Pignon, JP Cross-validation analysis of the prognostic significance of mucin expression in patients with resected non-small cell lung cancer treated with adjuvant chemotherapy: results from IALT, JBR.10 and ANITA.
Lung Cancer. 2013; 82(1):149-155 Doi: 10.1016/j.lungcan.2013.06.015 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Greimel, E; Kristensen, GB; van der Burg, ME; Coronado, P; Rustin, G; del Rio, AS; Reed, NS; Nordal, RR; Coens, C; Vergote, I; European Organization for Research and Treatment of Cancer - Gynaecological Cancer Group and NCIC Clinical Trials Group Quality of life of advanced ovarian cancer patients in the randomized phase III study comparing primary debulking surgery versus neo-adjuvant chemotherapy.
Gynecol Oncol. 2013; 131(2):437-444 Doi: 10.1016/j.ygyno.2013.08.014
Web of Science PubMed FullText FullText_MUG

 

Hofmann, G; Balic, M; Dandachi, N; Resel, M; Schippinger, W; Regitnig, P; Samonigg, H; Bauernhofer, T The predictive value of serum soluble E-cadherin levels in breast cancer patients undergoing preoperative systemic chemotherapy.
Clin Biochem. 2013; 46(15):1585-1589 Doi: 10.1016/j.clinbiochem.2013.06.010
Web of Science PubMed FullText FullText_MUG

 

Lindenmann, J; Matzi, V; Neuboeck, N; Anegg, U; Maier, A; Smolle, J; Smolle-Juettner, FM Multimodal therapy of malignant pleural mesothelioma: is the replacement of radical surgery imminent?
Interact Cardiovasc Thorac Surg. 2013; 16(3):237-243 Doi: 10.1093/icvts/ivs465 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Olaussen, KA; Adam, J; Vanhecke, E; Vielh, P; Pirker, R; Friboulet, L; Popper, H; Robin, A; Commo, F; Thomale, J; Kayitalire, L; Filipits, M; Le Chevalier, T; André, F; Brambilla, E; Soria, JC PARP1 impact on DNA repair of platinum adducts: preclinical and clinical read-outs.
Lung Cancer. 2013; 80(2):216-222 Doi: 10.1016/j.lungcan.2013.01.014 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Stöger, H Are the new breast cancer subtypes (luminal A, B etc.) of practical impact? Yes].
Dtsch Med Wochenschr. 2013; 138(41):2096-2096 Doi: 10.1055/s-0033-1349531
Web of Science PubMed FullText FullText_MUG

 

2012

Fajkovic, H; Cha, EK; Jeldres, C; Donner, G; Chromecki, TF; Margulis, V; Novara, G; Lotan, Y; Raman, JD; Kassouf, W; Seitz, C; Bensalah, K; Weizer, A; Kikuchi, E; Roscigno, M; Remzi, M; Matsumoto, K; Breinl, E; Pycha, A; Ficarra, V; Montorsi, F; Karakiewicz, PI; Scherr, DS; Shariat, SF Prognostic value of extranodal extension and other lymph node parameters in patients with upper tract urothelial carcinoma.
J Urol. 2012; 187(3): 845-851. Doi: 10.1016/j.juro.2011.10.158
Web of Science PubMed FullText FullText_MUG

 

Lannering, B; Rutkowski, S; Doz, F; Pizer, B; Gustafsson, G; Navajas, A; Massimino, M; Reddingius, R; Benesch, M; Carrie, C; Taylor, R; Gandola, L; Björk-Eriksson, T; Giralt, J; Oldenburger, F; Pietsch, T; Figarella-Branger, D; Robson, K; Forni, M; Clifford, SC; Warmuth-Metz, M; von Hoff, K; Faldum, A; Mosseri, V; Kortmann, R Hyperfractionated Versus Conventional Radiotherapy Followed by Chemotherapy in Standard-Risk Medulloblastoma: Results From the Randomized Multicenter HIT-SIOP PNET 4 Trial.
J Clin Oncol. 2012; 30(26):3187-3193 Doi: 10.1200/JCO.2011.39.8719 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Mazouni, C; Reitsamer, R; Rimareix, F; Stranzl, H; Uzan, C; Garbay, JR; Delaloge, S; Peintinger, F; The positive non-sentinel status is not the main decisional factor for chemotherapy assignment in breast cancer with micrometastatic disease in the sentinel lymph node.
J Surg Oncol. 2012; 106(6):703-707 Doi: 10.1002/jso.23188
Web of Science PubMed FullText FullText_MUG

 

Roupret, M; Zigeuner, R; Palou, J; Boehle, A; Kaasinen, E; Sylvester, R; Babjuk, M; Oosterlinck, W; European Association of Urology Guideline Group for urothelial cell carcinoma of the upper urinary tract European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. European Association of Urology Guideline Group for urothelial cell carcinoma of the upper urinary tract.
Actas Urol Esp. 2012; 36(1): 2-14. Doi: 10.1016/j.acuro.2011.09.001 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2011

Chromecki, TF; Cha, EK; Shariat, SF; Bladder Cancer Research Consortium Stage pT0 after radical cystectomy: are all patients equal?
EUR UROL. 2011; 60(3): 603-604. Doi: 10.1016/j.eururo.2011.05.050
Web of Science PubMed FullText FullText_MUG

 

Gnant, M; Mlineritsch, B; Stoeger, H; Luschin-Ebengreuth, G; Heck, D; Menzel, C; Jakesz, R; Seifert, M; Hubalek, M; Pristauz, G; Bauernhofer, T; Eidtmann, H; Eiermann, W; Steger, G; Kwasny, W; Dubsky, P; Hochreiner, G; Forsthuber, EP; Fesl, C; Greil, R; Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial.
Lancet Oncol. 2011; 12(7):631-641 Doi: 10.1016/S1470-2045(11)70122-X
Web of Science PubMed FullText FullText_MUG

 

Hofmann, G; Langsenlehner, U; Langsenlehner, T; Glehr, M; Gerger, A; Absenger, G; Szkandera, J; Fuerst, F; Samonigg, H; Krippl, P; Renner, W Single nucleotide polymorphisms of integrin alpha-2 and beta-3 genes are not associated with relapse-free and overall survival in colorectal cancer patients.
Anticancer Res. 2011; 31(4):1373-1377
Web of Science PubMed

 

Kornprat, P; Pollheimer, MJ; Lindtner, RA; Schlemmer, A; Rehak, P; Langner, C Value of tumor size as a prognostic variable in colorectal cancer: a critical reappraisal.
Am J Clin Oncol. 2011; 34(1):43-49 Doi: 10.1097/COC.0b013e3181cae8dd
Web of Science PubMed FullText FullText_MUG

 

Parmar, S; Stingl, JC; Huber-Wechselberger, A; Kainz, A; Renner, W; Langsenlehner, U; Krippl, P; Brockmöller, J; Haschke-Becher, E Impact of UGT2B7 His268Tyr polymorphism on the outcome of adjuvant epirubicin treatment in breast cancer.
Breast Cancer Res. 2011; 13(3):R57-R57 Doi: 10.1186/bcr2894 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Roscigno, M; Brausi, M; Heidenreich, A; Lotan, Y; Margulis, V; Shariat, SF; Van Poppel, H; Zigeuner, R Lymphadenectomy at the time of nephroureterectomy for upper tract urothelial cancer.
Eur Urol. 2011; 60(4): 776-783. Doi: 10.1016/j.eururo.2011.07.009
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Youssef, RF; Shariat, SF; Lotan, Y; Wood, CG; Sagalowsky, AI; Zigeuner, R; Kikuchi, E; Weizer, A; Raman, JD; Remzi, M; Kabbani, W; Langner, C; Guo, CC; Roscigno, M; Montorsi, F; Bolenz, C; Kassouf, W; Margulis, V Upper urinary tract urothelial carcinoma with loco-regional nodal metastases: insights from the Upper Tract Urothelial Carcinoma Collaboration.
BJU Int. 2011; 108(8): 1286-1291. Doi: 10.1111/j.1464-410X.2011.10075.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Zacherl, M; Bernhardt, GA; Zacherl, J; Gruber, G; Kornprat, P; Bacher, H; Mischinger, HJ; Windhager, R; Jakesz, R; Grünberger, T Surgery for liver metastases originating from sarcoma-case series.
Langenbecks Arch Surg. 2011; 396(7):1083-1091 Doi: 10.1007/s00423-011-0821-8
Web of Science PubMed FullText FullText_MUG

 

2010

Benesch, M; Weber-Mzell, D; Gerber, NU; von Hoff, K; Deinlein, F; Krauss, J; Warmuth-Metz, M; Kortmann, RD; Pietsch, T; Driever, PH; Quehenberger, F; Urban, C; Rutkowski, S Ependymoma of the spinal cord in children and adolescents: a retrospective series from the HIT database.
J Neurosurg Pediatr. 2010; 6(2): 137-144. Doi: 10.3171/2010.5.PEDS09553
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Erovic, BM; Schopper, C; Pammer, J; Vormittag, L; Maleki, A; Brunner, M; Heiduschka, G; Grasl, MCh; Thurnher, D Multimodal treatment of patients with minor salivary gland cancer in the case of recurrent disease.
Head Neck. 2010; 32(9):1167-1172 Doi: 10.1002/hed.21312
Web of Science PubMed FullText FullText_MUG

 

Hanzer, M; Nebl, A; Spendel, S; Pilhatsch, A; Urban, C; Benesch, M Necrosis of a skin autograft after short-term treatment with sunitinib in a 14-year-old girl with metastatic alveolar soft part sarcoma of the thigh.
Klin Padiatr. 2010; 222(3): 184-186. Doi: 10.1055/s-0030-1249093
Web of Science PubMed FullText FullText_MUG

 

Hoffmann, K; Franz, C; Hinz, U; Schirmacher, P; Herfarth, C; Eichbaum, M; Büchler, MW; Schemmer, P Liver resection for multimodal treatment of breast cancer metastases: identification of prognostic factors.
Ann Surg Oncol. 2010; 17(6):1546-1554 Doi: 10.1245/s10434-010-0931-5
Web of Science PubMed FullText FullText_MUG

 

Kamal, NS; Soria, JC; Mendiboure, J; Planchard, D; Olaussen, KA; Rousseau, V; Popper, H; Pirker, R; Bertrand, P; Dunant, A; Le Chevalier, T; Filipits, M; Fouret, P; International Adjuvant Lung Trial-Bio investigators MutS homologue 2 and the long-term benefit of adjuvant chemotherapy in lung cancer.
Clin Cancer Res. 2010; 16(4): 1206-1215. Doi: 10.1158/1078-0432.CCR-09-2204 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Sardanelli, F; Boetes, C; Borisch, B; Decker, T; Federico, M; Gilbert, FJ; Helbich, T; Heywang-Kobrunner, SH; Kaiser, WA; Kerin, MJ; Mansel, RE; Marotti, L; Martincich, L; Mauriac, L; Meijers-Heijboer, H; Orecchia, R; Panizza, P; Ponti, A; Purushotham, AD; Regitnig, P; Del Turco, MR; Thibault, F; Wilson, R Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group.
EUR J CANCER. 2010; 46(8): 1296-1316. Doi: 10.1016/j.ejca.2010.02.015
Web of Science PubMed FullText FullText_MUG

 

Symmans, WF; Hatzis, C; Sotiriou, C; Andre, F; Peintinger, F; Regitnig, P; Daxenbichler, G; Desmedt, C; Domont, J; Marth, C; Delaloge, S; Bauernhofer, T; Valero, V; Booser, DJ; Hortobagyi, GN; Pusztai, L Genomic Index of Sensitivity to Endocrine Therapy for Breast Cancer.
J Clin Oncol. 2010; 28(27): 4111-4119. Doi: 10.1200/JCO.2010.28.4273 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Weitere 50 Treffer anzeigen

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum